We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
biomodal Logo

biomodal

biomodal is focused on building technologies as research tools for life scientists and clinical developers. Their technology allows you to capture the 6-base genome and provide insight into the complexity and dynamism of cellular interactions. biomodal's platform works with your existing infrastructure, integrating a pre-sequencing workflow with post-sequencing informatics to generate highly accurate genetic and epigenetic data from a single sample in a single run.

Latest biomodal Content

The Landscape of Cancer Research: Advances in Immuno-oncology
Online Event

The Landscape of Cancer Research: Advances in Immuno-oncology 2024

On-Demand
Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.
Genetics
Poster

Measuring Genetics and Epigenetics at Single-Base Resolution

This poster highlights a cutting-edge sequencing technology which can simultaneously resolve all four genetic bases alongside cytosine modification status.
Headshot of Dr. Joanne Mason sitting at a desk.
Industry Insight

Women in Science – A Conversation With Dr. Joanne Mason

In this interview, Dr. Mason tells us about her career path and experiences along the way, as well as sharing advice for women considering a career in science.
Biological insights into genetics
Poster

Simultaneous Measurement of Genetics and Epigenetics Enables New Biological Insight

There is more to DNA than A, C, G and T, epigenetics plays a causal role in cell fate, aging and disease development. Genetic and methylation data together on the same read allow us to get a more complete picture of genome biology. Constrained to measuring four states of information, existing NGS- based technologies sacrifice genetic for methylation calling.
Liquid Biopsy
Poster

Refining Liquid Biopsy: Generating More Information From Cell Free DNA

Liquid biopsy for profiling of cell free DNA (cfDNA) in blood holds huge promise to transform how we experience and manage cancer by early detection and identification of residual disease and subtype. However, a standard blood draw yields an average of only 10 ng of cfDNA, of which DNA derived from the tumor is a small minority.
Revealing the Combinatorial Power of Genetic and Epigenetic Information for Early Cancer Detection content piece image
Video

Revealing the Combinatorial Power of Genetic and Epigenetic Information for Early Cancer Detection

In this episode we discuss how the combination of both genetic and epigenetic information within a single DNA sample can provide key insights on the dynamic interactions that are occurring, offering significant advantages in many research areas.
Unlocking the Potential of Genetics and Epigenetics for Early Cancer Detection content piece image
Video

Unlocking the Potential of Genetics and Epigenetics for Early Cancer Detection

In this Teach me in 10 episode we will explore how simultaneous sequencing of genetic and epigenetic bases in cfDNA allows for early cancer detection.
Advertisement